📰 Quotient Sciences News
Page 10 - Quotient Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quotient Sciences. Real-time updates on events, politics, business and more.
March 30, 2023
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial ...
March 6, 2023
~ Ensysce Biosciences and Quotient Sciences Showcase a Unique Collaboration ~SAN DIEGO, CA / ACCESSWIRE / March 6, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage
February 24, 2023
Ingenza is excited to welcome Dr Mark Chadwick to the team as Strategic Business Advisor. Mark will bring extensive industry expertise to his new position at Ingenza, acquired over 30 years from a variety of roles within small growth companies, covering the areas of biotechnology, drug discovery and drug development.
February 23, 2023
Answers Recently Asked QuestionsSAN DIEGO, CA / ACCESSWIRE / February 23, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech company applying transformative
February 19, 2023
This case study demonstrates rapid development, clinical assessment and commercial readiness of DRGT-46, a novel composition of Celecoxib, using...
February 16, 2023
02/16/23 Pharmaceutical Online Newsletter
February 14, 2023
/PRNewswire/ -- Roots Analysis has announced the addition of "Bioavailability Enhancement Technologies and Services Market (2nd Edition), 2022-2035" report to...
February 8, 2023
/PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, today announced that it has completed an expansion of its early-phase...
January 25, 2023
~ PF614-MPAR to be the Industry's First Overdose Protection Pain Product ~SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), (OTC PINK:ENSCW)
January 25, 2023
25.01.2023 - ~ PF614-MPAR to be the Industrys First Overdose Protection Pain Product ~SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. (Ensysce or the Company) (NASDAQ:ENSC), (OTC PINK:ENSCW), a clinical-stage biotech company ... Seite 1